ANI PHARMACEUTICALS INC
Public company- Headquarters
- PRINCETON, New Jersey
- Ticker
- ANIP
- CIK
- 0001023024
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
2
1 appointment, 1 departure
Last event
Aug 24, 2026
Executive appointmentdirector appointed: Henry Gosebruch
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorHenry Gosebruch | Aug 24, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- ELITE PHARMACEUTICALS INC /NV/
Class I director appointed: John W. LaRocca, Esq.
- Executive appointment
director appointed: Henry Gosebruch
Henry Gosebruch was named director of ANI PHARMACEUTICALS INC, effective August 19, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 24, 2026Role: director
- Executive departure
director departs: Muthusamy “Samy” Shanmugam
Muthusamy “Samy” Shanmugam, director of ANI PHARMACEUTICALS INC, resigns the role, effective August 23, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 24, 2026Role: director
Last verified Nov 8, 2026